Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Risk Factors for Thrombosis in Essential Thrombocythemia: A Clinico-Pathological Study of 138 Patents in a Middle Eastern Population

Aamer Aleem, Abdullah Alqahtani, Leena Alshaman, Nawaf Aldawsari, Farjah Algahtani, Ahmed Jamal, Zafar Iqbal, Musa Alzahrani, Khalid AlSaleh, Sarah Sewaralthahab, Fatimah Alshalati, Naif Saud Albudayri, Ghazi S Alotaibi

Blood (2023) 142 (Supplement 1): 6435.

https://doi.org/10.1182/blood-2023-190259

Published: 2023

Journal Articles

Discovery of Mutated MUC3A Gene As a Novel Transcription Factor Exclusively Associated with Accelerated Phase Chronic Myeloid Leukemia: Hunt for Common Biomarker of Fatal CML Progression

Sameen Shahid, Muhammad Sabar, Abid Jamil, Muhammad Abbas Khokar, Muhammad Absar, Mudassar Iqbal, Masood A. Shammas, Giuseppe Saglio, Sulman Basit, Sibtain Afzal, Khushnooda Ramzan, Aamer Aleem, Amer Mahmood, Nawaf Alanzazi, Muhammad Javed Asif, Mahmood Rasool, Ahmad Khalid, Zafar Iqbal

Blood (2023) 142 (Supplement 1): 7429.

https://doi.org/10.1182/blood-2023-185547

Published: 2023

Journal Articles

Clinical and Pathologic Characteristics of Essential Thrombocythemia (ET) Patients Harboring Calreticulin (CALR) Mutations

Aamer Aleem, Abdullah Algahtani, Leena Alshaman, Nawaf Aldawsari, Farjah Alqahtani, Musa Alzahrani, Ghazi Alotaibi, Saeed Alturki, Zafar Iqbal

Blood (2022) 140 (Supplement 1): 12282–12283.

https://doi.org/10.1182/blood-2022-169941

Published: 2022

Journal Articles

Discovery of Mutated ZNF208 Gene As a Novel Transcription Factor Exclusively Associated with Accelerated Phase and Blast Crisis Chronic Myeloid Leukemia: Hunt for Common Biomarker of Fatal CML Progression

Nawaf Alanazi, Zafar Iqbal

Blood (2022) 140 (Supplement 1): 12233–12234.

https://doi.org/10.1182/blood-2022-170015

Published: 2022

Journal Articles

Discontinuation of Tyrosine Kinase Inhibitor Therapy and Treatment-Free Remission in Chronic-Phase Chronic Myeloid Leukemia: An Observational Retrospective Multi-Center Study

Aamer Aleem, Farjah Alqahtani, Ahmed Jamal, Nora A. Alkhudair, Mashail Alghafis, Hajar Wan Zuki Siti, Bader Alahmari, Hend Salama, Giamal Edin Gmati, Mohsen Alzahrani, Ayman Alhejazi, Naila A. Shaheen, Abdullah M Alrajhi, Mansour Alfayez, Zafar Iqbal, Ahmed Alaskar

Blood (2022) 140 (Supplement 1): 12220–12221.

https://doi.org/10.1182/blood-2022-168926

Published: 2022

Journal Articles

High-Throughput DNA Sequencing Identifies a Novel Splice-Site Mutation in Fanconi Anemia Pathway Gene FANCD2 As a Potential Biomarker of Early and Late Phases of Disease Progression in Chronic Myeloid Leukemia

Nawaf Alanazi, Zafar Iqbal

Blood (2022) 140 (Supplement 1): 12155–12157.

https://doi.org/10.1182/blood-2022-170476

Published: 2022

Journal Articles

Next-Generation Sequencing Identifies a Previously Uncharacterized Gene ANKRD36 As a Common Biomarker for Blast Crisis Chronic Myeloid Leukemia: Molecular and Protein Bio-Modeling Studies

Blood (2020) 136 (Supplement 1): 32–33.

https://doi.org/10.1182/blood-2020-143068

Published: 2020

Journal Articles

Investigations on Novel Gene Variants Associated with Longterm Response to Tyrosine Kinase Inhibitors (TKIs) in Chronic Myeloid Leukemia: Implication in TKI-Cessation Clinical Trails

Zafar Iqbal, BSc, MSc, PhD, Muhammad Absar, BSc, MSc, PhD, Abid Jameel, MD PhD, Tanveer Akhtar, PhD, Sulman Basit, PhDMSc, Aamer Mahmood, PhD, Aamir Aleem, MBBS FRCP, Nawaf Alanazi, MBBS FRCPC, Ullah Anhar, Naila Batool Khalid, Sibtain Afzal, Jamil Amjad Hashmi, Afia M Akram, PhD, Khushnooda Ramzan, PhD, Mahmood Rasool, Muhammad Hasaan Aziz, Muhammad Farooq Sabar, PhD, Mudassar Iqbal, MDMS, Ahmad Mukhtar Khalid, PhD

Blood (2019) 134 (Supplement_1): 2939.

https://doi.org/10.1182/blood-2019-125518

Published: 2019

Journal Articles

BCR-ABL Kinase Domain Mutations Exist in Few Imatinib Treated Chronic Myeloid Leukemia (CML) Patients Exhibiting Stable Cytogenetic and Hematologic Responses

Afia Muhammad Akram, PhD, Tanveer Akhtar, PhD, Asma Chaudhary, Muhammad Mudassar Shahzad, Ahmad Mukhtar Khalid, PhD, Nadia Sajid, MBBS, FCPS, Muhammad Farooq Sabar, PhD, Zafar Iqbal, BSc, MSc, PhD

Blood (2018) 132 (Supplement 1): 5427.

https://doi.org/10.1182/blood-2018-99-111757

Published: 2018

Journal Articles

Impact of Red Blood Cell Transfusions on Height and Growth of Adolescents with Sickle Cell Disease & Short Stature

Aamer Aleem, MBBS, FRCP, FRCPath, Abdulrahman Alsultan, Ammara Afzal, MD, Sami Alotaibi, MD, Zafar Iqbal, BSc, MSc, PhD, Khalid AlSaleh, MBBS, FRCPC, MRCP

Blood (2018) 132 (Supplement 1): 4935.

https://doi.org/10.1182/blood-2018-99-111591

Published: 2018

Journal Articles

Disovery of Novel Mutations Exclusively Shared By Accelerated and Blast Crisis Phase CML Patients Using Whole Exome Sequencing:Implication in Hunt for Common Biomarker /Drug Target of CML Progression

Zafar Iqbal, MPhil PhD, Salman Basit, PhD, Abid Jamil, MDPhD, Muhammad Absar, Anhar Ullah, MS, Sibtain Afzal, Aamer Mahmood, PhD, Khushnooda Ramzan, PhD, Aamir Aleem, Jamil Amjad Hashmi, Noor Rehman, Khalid Aljamaan, Saleh Aloraibi, Giuseppe Saglio, MD PhD, Nawaf Alanazi, Mudassar Iqbal, MDMS, Tanveer Akhtar

Blood (2017) 130 (Supplement 1): 2886.

https://doi.org/10.1182/blood.V130.Suppl_1.2886.2886

Published: 2017

Journal Articles

Ameliorating Effects of Very High Hemoglobin F Levels and Glucose-6-Phosphate Dehydrogenase Deficiency in Sickle Cell Patients Along with Associated Clinical Manifestations: A Report from Al Ahsa, Easter Province, Saudi Arabia

Nawaf Alanazi, Alhussain, J . Almulhim, S . AlJaman, M . AlAmer, L . BuAmer , W. Almutlaq, M, AbudalloHull Rula, Giuseppe Saglio, MD PhD, Zafar Iqbal, MPhil PhD

Blood (2017) 130 (Supplement 1): 4803.

https://doi.org/10.1182/blood.V130.Suppl_1.4803.4803

Published: 2017

Journal Articles

First Report on Elevated Transcranial Doppler Ultrasound Velocities As First Stroke Risk and Their Association with Hemoglobin F Expression in Saudi Arabian Pediatric Sickle Cell Patients

Khalid Al Jamaan, MDFRCPC, Saleh Al Oraibi, Giuseppe Saglio, MD, Mudassar Iqbal, MD MS, Zafar Iqbal, MPhil PhDPostdoc

Blood (2016) 128 (22): 3665.

https://doi.org/10.1182/blood.V128.22.3665.3665

Published: 2016

Journal Articles

Brief Research Report: Novel Compound BCR-ABL Mutations in Late Chronic Phase Imatinib Sensitive CML Patients Are Associated with Progression to Advance Disease Phase

Zafar Iqbal, MPhil PhDPost-doc., Afia Muhammad Akram, Tanveer Akhtar, PhD, Aamer Aleem, MBBS FRCP, Muhammad Farooq Sabar, PhD, Zeba Aziz, MD MBBS, Nadia Sajid, Mahmood Rasool, PhD, Muhammad Asif, Mehmood Husssain Qazi, PhD, Saleh Oraibi, PhD, Ammara T Gill, MBBS ABIM, Khalid Al Jamaan, MDFRCPC, Mudassar Iqbal, MDMS, Ahmad Mukhtar Khalid

Blood (2016) 128 (22): 3089.

https://doi.org/10.1182/blood.V128.22.3089.3089

Published: 2016

Journal Articles

Multiple Brain Hemorrhages on Presentation in a Patient with Accelerated Phase Chronic Myeloid Leukemia and Subsequent CNS Blast Crisis Despite Systemic Complete Molecular Response: Possible Role of CNS Bleed in Leukemia Proliferation

Aleem Aamer, MBBS, FRCP, FRCPath, Fatmah Al Wusibai, MBBS, Khalid AlSaleh, MBBS, FRCPC, MRCP, Fatma Alqahtani, MBBS, KSU fellowship, Zafar Iqbal, PhD, Naeem A. Chaudhri, MD FACP, Abdul Kareem M Al-Momen, MD FRCPC

Blood (2015) 126 (23): 5153.

https://doi.org/10.1182/blood.V126.23.5153.5153

Published: 2015

Journal Articles

Low Representation of ETV6-RUNX1 Fusion Oncogene in Pediatric Acute Lymphoblastic Leukemia Patients from Saudi Arabia and Strong Association with Clinical Response to Day-14 of Remission Induction Therapy

Khalid Aljamaan, MD, Talal Khalid Aljumah, MBBS, Saleh Aloraibi, PhD, Muhammad Absar, MSc PhD, Giuseppe Saglio, MD, Zafar Iqbal, MPhil PhD

Blood (2015) 126 (23): 4987.

https://doi.org/10.1182/blood.V126.23.4987.4987

Published: 2015

Journal Articles

High Frequencies of Compound BCR-ABL Mutations and Their Association with Imatinib Resistant, Disease Progression and Late Chronic Phase Disease in Pakistani Chronic Myeloid Leukemia Patients Necessitate the Inclusion of Molecular Testing in Routine Clinical Settings

Zafar Iqbal, PhD, Afia Muhammad Akram, Tanveer Akhtar, PhD, Muhammad Khalid, MPhil PhD, Zeba Aziz, MD MBBS, Aamer Aleem, MBBS FRCP, Ammara T Gill, MBBS ABIM, Ahmad M Khalid, PhD, Abdullah Alanazi, MBBS, Ijaz H Shah, MD, Muhammad Khalid, MBBS, MPhil, Muhammad Farooq Sabar, PhD, Mudassar Iqbal

Blood (2015) 126 (23): 5167.

https://doi.org/10.1182/blood.V126.23.5167.5167

Published: 2015

Journal Articles

Detection of Compound BCR-ABL Mutations in TKI Resistant CML Patients Including a Novel K245N Mutation Associated with Primary Nilotinib Resistance By Employing a Newly Developed Cost Effective BCR-ABL Sequencing Protocol

Blood (2014) 124 (21): 1810.

https://doi.org/10.1182/blood.V124.21.1810.1810

Published: 2014

Journal Articles

High Frequency Of BCR-ABL/t(22;9) Translocation As Detected By RT-PCR and Interphase FISH In Pediatric B-Cell ALL Patients Identifies The Need For Immediate Inclusion Of Tyrosine Kinase Inhibitors In Pediatric ALL Treatment Protocols

Zafar Iqbal, MPhil PhD Post-doctorate, Tashfin Awan, MSc PhD, Tanveer Akhtar, MSc, PhD, Aleem Aamer, MBBS MRCP FRCPath, Noreen Sabir, MSc PhD, Muhammad Absar, MSc, Iqbal Mudassar, MD MS, Ahmad Mukhtar Khalid, MSc, PhD, Giuseppe Saglio, MD, Mahmood Rasool, Akhtar Hussain, BS MPhil

Blood (2013) 122 (21): 3908.

https://doi.org/10.1182/blood.V122.21.3908.3908

Published: 2013

Journal Articles

Detection of Five Common Fusion Oncogenes in Pakistani Children with Acute Lymphoblastic Leukemia and Their Association with Clinical Pattern and Treatment Outcome

Blood (2012) 120 (21): 5124.

https://doi.org/10.1182/blood.V120.21.5124.5124

Published: 2012

NARROW

Risk Factors for Thrombosis in Essential Thrombocythemia: A Clinico-Pathological Study of 138 Patents in a Middle Eastern Population

Discovery of Mutated MUC3A Gene As a Novel Transcription Factor Exclusively Associated with Accelerated Phase Chronic Myeloid Leukemia: Hunt for Common Biomarker of Fatal CML Progression

Clinical and Pathologic Characteristics of Essential Thrombocythemia (ET) Patients Harboring Calreticulin (CALR) Mutations

Discovery of Mutated ZNF208 Gene As a Novel Transcription Factor Exclusively Associated with Accelerated Phase and Blast Crisis Chronic Myeloid Leukemia: Hunt for Common Biomarker of Fatal CML Progression

Discontinuation of Tyrosine Kinase Inhibitor Therapy and Treatment-Free Remission in Chronic-Phase Chronic Myeloid Leukemia: An Observational Retrospective Multi-Center Study

High-Throughput DNA Sequencing Identifies a Novel Splice-Site Mutation in Fanconi Anemia Pathway Gene FANCD2 As a Potential Biomarker of Early and Late Phases of Disease Progression in Chronic Myeloid Leukemia

Next-Generation Sequencing Identifies a Previously Uncharacterized Gene ANKRD36 As a Common Biomarker for Blast Crisis Chronic Myeloid Leukemia: Molecular and Protein Bio-Modeling Studies

Investigations on Novel Gene Variants Associated with Longterm Response to Tyrosine Kinase Inhibitors (TKIs) in Chronic Myeloid Leukemia: Implication in TKI-Cessation Clinical Trails

BCR-ABL Kinase Domain Mutations Exist in Few Imatinib Treated Chronic Myeloid Leukemia (CML) Patients Exhibiting Stable Cytogenetic and Hematologic Responses

Impact of Red Blood Cell Transfusions on Height and Growth of Adolescents with Sickle Cell Disease & Short Stature

Disovery of Novel Mutations Exclusively Shared By Accelerated and Blast Crisis Phase CML Patients Using Whole Exome Sequencing:Implication in Hunt for Common Biomarker /Drug Target of CML Progression

Ameliorating Effects of Very High Hemoglobin F Levels and Glucose-6-Phosphate Dehydrogenase Deficiency in Sickle Cell Patients Along with Associated Clinical Manifestations: A Report from Al Ahsa, Easter Province, Saudi Arabia

First Report on Elevated Transcranial Doppler Ultrasound Velocities As First Stroke Risk and Their Association with Hemoglobin F Expression in Saudi Arabian Pediatric Sickle Cell Patients

Brief Research Report: Novel Compound BCR-ABL Mutations in Late Chronic Phase Imatinib Sensitive CML Patients Are Associated with Progression to Advance Disease Phase

Multiple Brain Hemorrhages on Presentation in a Patient with Accelerated Phase Chronic Myeloid Leukemia and Subsequent CNS Blast Crisis Despite Systemic Complete Molecular Response: Possible Role of CNS Bleed in Leukemia Proliferation

Low Representation of ETV6-RUNX1 Fusion Oncogene in Pediatric Acute Lymphoblastic Leukemia Patients from Saudi Arabia and Strong Association with Clinical Response to Day-14 of Remission Induction Therapy

High Frequencies of Compound BCR-ABL Mutations and Their Association with Imatinib Resistant, Disease Progression and Late Chronic Phase Disease in Pakistani Chronic Myeloid Leukemia Patients Necessitate the Inclusion of Molecular Testing in Routine Clinical Settings

Detection of Compound BCR-ABL Mutations in TKI Resistant CML Patients Including a Novel K245N Mutation Associated with Primary Nilotinib Resistance By Employing a Newly Developed Cost Effective BCR-ABL Sequencing Protocol

High Frequency Of BCR-ABL/t(22;9) Translocation As Detected By RT-PCR and Interphase FISH In Pediatric B-Cell ALL Patients Identifies The Need For Immediate Inclusion Of Tyrosine Kinase Inhibitors In Pediatric ALL Treatment Protocols

Detection of Five Common Fusion Oncogenes in Pakistani Children with Acute Lymphoblastic Leukemia and Their Association with Clinical Pattern and Treatment Outcome

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only